 | • レポートコード：GIR201114170 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、糖尿病治療薬の世界市場を調査対象にし、糖尿病治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（インスリン、増感剤、SGLT-2阻害剤、α-グルコシダーゼ阻害剤、分泌促進剤、ペプチド類似体、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Eli Lilly、Novartis、AstraZeneca、Novo Nordisk、Sanofi、Abbott、Pfizer、Sunpharma、Biocon、Merck、Adocia、Daiichi Sankyo、Peptron、Amgen、Boehringer Ingelheim、Takeda、Akros Pharma ・企業別売上、市場シェア ・糖尿病治療薬の地域別市場分析 ・糖尿病治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・糖尿病治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・糖尿病治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・糖尿病治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・糖尿病治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・糖尿病治療薬の種類別市場規模2015-2020：インスリン、増感剤、SGLT-2阻害剤、α-グルコシダーゼ阻害剤、分泌促進剤、ペプチド類似体、その他 ・糖尿病治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・糖尿病治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Diabetes Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 80080 million by 2025, from USD 65460 million in 2019.
The Diabetes Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diabetes Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diabetes Drug market has been segmented into:
Insulin
Sensitizers
SGLT-2 Inhibitors
Alpha-glucosidase Inhibitors
Secretagogues
Peptide Analogs
Others
By Application, Diabetes Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diabetes Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Diabetes Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diabetes Drug market.
The report offers in-depth assessment of the growth and other aspects of the Diabetes Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diabetes Drug Market Share Analysis
Diabetes Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diabetes Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diabetes Drug sales, revenue and market share for each player covered in this report.
The major players covered in Diabetes Drug are:
Eli Lilly
Novartis
AstraZeneca
Novo Nordisk
Sanofi
Abbott
Pfizer
Sunpharma
Biocon
Merck
Adocia
Daiichi Sankyo
Peptron
Amgen
Boehringer Ingelheim
Takeda
Akros Pharma
Table of Contents
1 Diabetes Drug Market Overview
1.1 Product Overview and Scope of Diabetes Drug
1.2 Classification of Diabetes Drug by Type
1.2.1 Global Diabetes Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diabetes Drug Revenue Market Share by Type in 2019
1.2.3 Insulin
1.2.4 Sensitizers
1.2.5 SGLT-2 Inhibitors
1.2.6 Alpha-glucosidase Inhibitors
1.2.7 Secretagogues
1.2.8 Peptide Analogs
1.2.9 Others
1.3 Global Diabetes Drug Market by Application
1.3.1 Overview: Global Diabetes Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Diabetes Drug Market by Regions
1.4.1 Global Diabetes Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diabetes Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diabetes Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diabetes Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetes Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diabetes Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetes Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novo Nordisk SWOT Analysis
2.4.4 Novo Nordisk Product and Services
2.4.5 Novo Nordisk Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sunpharma
2.8.1 Sunpharma Details
2.8.2 Sunpharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sunpharma SWOT Analysis
2.8.4 Sunpharma Product and Services
2.8.5 Sunpharma Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Adocia
2.11.1 Adocia Details
2.11.2 Adocia Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Adocia SWOT Analysis
2.11.4 Adocia Product and Services
2.11.5 Adocia Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Daiichi Sankyo
2.12.1 Daiichi Sankyo Details
2.12.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Daiichi Sankyo SWOT Analysis
2.12.4 Daiichi Sankyo Product and Services
2.12.5 Daiichi Sankyo Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 Peptron
2.13.1 Peptron Details
2.13.2 Peptron Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Peptron SWOT Analysis
2.13.4 Peptron Product and Services
2.13.5 Peptron Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Amgen SWOT Analysis
2.14.4 Amgen Product and Services
2.14.5 Amgen Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.15 Boehringer Ingelheim
2.15.1 Boehringer Ingelheim Details
2.15.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Boehringer Ingelheim SWOT Analysis
2.15.4 Boehringer Ingelheim Product and Services
2.15.5 Boehringer Ingelheim Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.16 Takeda
2.16.1 Takeda Details
2.16.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Takeda SWOT Analysis
2.16.4 Takeda Product and Services
2.16.5 Takeda Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
2.17 Akros Pharma
2.17.1 Akros Pharma Details
2.17.2 Akros Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Akros Pharma SWOT Analysis
2.17.4 Akros Pharma Product and Services
2.17.5 Akros Pharma Diabetes Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diabetes Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetes Drug Players Market Share
3.2.2 Top 10 Diabetes Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diabetes Drug Revenue and Market Share by Regions
4.2 North America Diabetes Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Diabetes Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diabetes Drug Revenue and Growth Rate (2015-2020)
4.5 South America Diabetes Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diabetes Drug Revenue and Growth Rate (2015-2020)
5 North America Diabetes Drug Revenue by Countries
5.1 North America Diabetes Drug Revenue by Countries (2015-2020)
5.2 USA Diabetes Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Diabetes Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Diabetes Drug Revenue and Growth Rate (2015-2020)
6 Europe Diabetes Drug Revenue by Countries
6.1 Europe Diabetes Drug Revenue by Countries (2015-2020)
6.2 Germany Diabetes Drug Revenue and Growth Rate (2015-2020)
6.3 UK Diabetes Drug Revenue and Growth Rate (2015-2020)
6.4 France Diabetes Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Diabetes Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Diabetes Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diabetes Drug Revenue by Countries
7.1 Asia-Pacific Diabetes Drug Revenue by Countries (2015-2020)
7.2 China Diabetes Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Diabetes Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Diabetes Drug Revenue and Growth Rate (2015-2020)
7.5 India Diabetes Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diabetes Drug Revenue and Growth Rate (2015-2020)
8 South America Diabetes Drug Revenue by Countries
8.1 South America Diabetes Drug Revenue by Countries (2015-2020)
8.2 Brazil Diabetes Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Diabetes Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diabetes Drug by Countries
9.1 Middle East & Africa Diabetes Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diabetes Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Diabetes Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Diabetes Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Diabetes Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diabetes Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Diabetes Drug Market Forecast by Type (2019-2024)
10.3 Insulin Revenue Growth Rate (2015-2025)
10.4 Sensitizers Revenue Growth Rate (2015-2025)
10.5 SGLT-2 Inhibitors Revenue Growth Rate (2015-2025)
10.6 Alpha-glucosidase Inhibitors Revenue Growth Rate (2015-2025)
10.7 Secretagogues Revenue Growth Rate (2015-2025)
10.8 Peptide Analogs Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Diabetes Drug Market Segment by Application
11.1 Global Diabetes Drug Revenue Market Share by Application (2015-2020)
11.2 Diabetes Drug Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Diabetes Drug Market Size Forecast (2021-2025)
12.1 Global Diabetes Drug Market Size Forecast (2021-2025)
12.2 Global Diabetes Drug Market Forecast by Regions (2021-2025)
12.3 North America Diabetes Drug Revenue Market Forecast (2021-2025)
12.4 Europe Diabetes Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diabetes Drug Revenue Market Forecast (2021-2025)
12.6 South America Diabetes Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diabetes Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diabetes Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diabetes Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diabetes Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diabetes Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Diabetes Drug Major Business
Table 7. Eli Lilly Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Diabetes Drug Product and Solutions
Table 10. Eli Lilly Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Diabetes Drug Major Business
Table 13. Novartis Diabetes Drug Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Diabetes Drug Product and Solutions
Table 16. Novartis Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AstraZeneca Corporate Information, Location and Competitors
Table 18. AstraZeneca Diabetes Drug Major Business
Table 19. AstraZeneca Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 20. AstraZeneca SWOT Analysis
Table 21. AstraZeneca Diabetes Drug Product and Solutions
Table 22. AstraZeneca Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novo Nordisk Corporate Information, Location and Competitors
Table 24. Novo Nordisk Diabetes Drug Major Business
Table 25. Novo Nordisk Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 26. Novo Nordisk SWOT Analysis
Table 27. Novo Nordisk Diabetes Drug Product and Solutions
Table 28. Novo Nordisk Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Diabetes Drug Major Business
Table 31. Sanofi Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Diabetes Drug Product and Solutions
Table 34. Sanofi Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Diabetes Drug Major Business
Table 37. Abbott Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Diabetes Drug Product and Solutions
Table 40. Abbott Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Diabetes Drug Major Business
Table 43. Pfizer Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Diabetes Drug Product and Solutions
Table 46. Pfizer Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sunpharma Corporate Information, Location and Competitors
Table 48. Sunpharma Diabetes Drug Major Business
Table 49. Sunpharma Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 50. Sunpharma SWOT Analysis
Table 51. Sunpharma Diabetes Drug Product and Solutions
Table 52. Sunpharma Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Biocon Corporate Information, Location and Competitors
Table 54. Biocon Diabetes Drug Major Business
Table 55. Biocon Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 56. Biocon SWOT Analysis
Table 57. Biocon Diabetes Drug Product and Solutions
Table 58. Biocon Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck Corporate Information, Location and Competitors
Table 60. Merck Diabetes Drug Major Business
Table 61. Merck Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 62. Merck SWOT Analysis
Table 63. Merck Diabetes Drug Product and Solutions
Table 64. Merck Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Adocia Corporate Information, Location and Competitors
Table 66. Adocia Diabetes Drug Major Business
Table 67. Adocia Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 68. Adocia SWOT Analysis
Table 69. Adocia Diabetes Drug Product and Solutions
Table 70. Adocia Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Daiichi Sankyo Corporate Information, Location and Competitors
Table 72. Daiichi Sankyo Diabetes Drug Major Business
Table 73. Daiichi Sankyo Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 74. Daiichi Sankyo SWOT Analysis
Table 75. Daiichi Sankyo Diabetes Drug Product and Solutions
Table 76. Daiichi Sankyo Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Peptron Corporate Information, Location and Competitors
Table 78. Peptron Diabetes Drug Major Business
Table 79. Peptron Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 80. Peptron SWOT Analysis
Table 81. Peptron Diabetes Drug Product and Solutions
Table 82. Peptron Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Amgen Corporate Information, Location and Competitors
Table 84. Amgen Diabetes Drug Major Business
Table 85. Amgen Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 86. Amgen SWOT Analysis
Table 87. Amgen Diabetes Drug Product and Solutions
Table 88. Amgen Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 90. Boehringer Ingelheim Diabetes Drug Major Business
Table 91. Boehringer Ingelheim Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 92. Boehringer Ingelheim SWOT Analysis
Table 93. Boehringer Ingelheim Diabetes Drug Product and Solutions
Table 94. Boehringer Ingelheim Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Takeda Corporate Information, Location and Competitors
Table 96. Takeda Diabetes Drug Major Business
Table 97. Takeda Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 98. Takeda SWOT Analysis
Table 99. Takeda Diabetes Drug Product and Solutions
Table 100. Takeda Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Akros Pharma Corporate Information, Location and Competitors
Table 102. Akros Pharma Diabetes Drug Major Business
Table 103. Akros Pharma Diabetes Drug Total Revenue (USD Million) (2017-2018)
Table 104. Akros Pharma SWOT Analysis
Table 105. Akros Pharma Diabetes Drug Product and Solutions
Table 106. Akros Pharma Diabetes Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Diabetes Drug Revenue (Million USD) by Players (2015-2020)
Table 108. Global Diabetes Drug Revenue Share by Players (2015-2020)
Table 109. Global Diabetes Drug Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Diabetes Drug Revenue Market Share by Regions (2015-2020)
Table 111. North America Diabetes Drug Revenue by Countries (2015-2020)
Table 112. North America Diabetes Drug Revenue Market Share by Countries (2015-2020)
Table 113. Europe Diabetes Drug Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Diabetes Drug Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Diabetes Drug Revenue by Countries (2015-2020)
Table 116. South America Diabetes Drug Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Diabetes Drug Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Diabetes Drug Revenue Market Share by Countries (2015-2020)
Table 119. Global Diabetes Drug Revenue (Million USD) by Type (2015-2020)
Table 120. Global Diabetes Drug Revenue Share by Type (2015-2020)
Table 121. Global Diabetes Drug Revenue Forecast by Type (2021-2025)
Table 122. Global Diabetes Drug Revenue by Application (2015-2020)
Table 123. Global Diabetes Drug Revenue Share by Application (2015-2020)
Table 124. Global Diabetes Drug Revenue Forecast by Application (2021-2025)
Table 125. Global Diabetes Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diabetes Drug Picture
Figure 2. Global Diabetes Drug Revenue Market Share by Type in 2019
Figure 3. Insulin Picture
Figure 4. Sensitizers Picture
Figure 5. SGLT-2 Inhibitors Picture
Figure 6. Alpha-glucosidase Inhibitors Picture
Figure 7. Secretagogues Picture
Figure 8. Peptide Analogs Picture
Figure 9. Others Picture
Figure 10. Diabetes Drug Revenue Market Share by Application in 2019
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Others Picture
Figure 14. Global Diabetes Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Diabetes Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Diabetes Drug Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Diabetes Drug Revenue Market Share in 2019
Figure 23. Global Top 10 Players Diabetes Drug Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Diabetes Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Diabetes Drug Revenue Market Share by Regions (2015-2020)
Figure 27. Global Diabetes Drug Revenue Market Share by Regions in 2018
Figure 28. North America Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 29. Europe Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 31. South America Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 33. North America Diabetes Drug Revenue Market Share by Countries (2015-2020)
Figure 34. North America Diabetes Drug Revenue Market Share by Countries in 2019
Figure 35. USA Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 36. Canada Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 38. Europe Diabetes Drug Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Diabetes Drug Revenue Market Share by Countries in 2019
Figure 40. Germany Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 41. UK Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 42. France Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 43. Russia Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 44. Italy Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Diabetes Drug Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Diabetes Drug Revenue Market Share by Countries in 2019
Figure 47. China Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 48. Japan Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 49. Korea Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 50. India Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 52. South America Diabetes Drug Revenue Market Share by Countries (2015-2020)
Figure 53. South America Diabetes Drug Revenue Market Share by Countries in 2019
Figure 54. Brazil Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Diabetes Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Diabetes Drug Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 59. UAE Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Diabetes Drug Revenue and Growth Rate (2015-2020)
Figure 62. Global Diabetes Drug Revenue Share by Type (2015-2020)
Figure 63. Global Diabetes Drug Revenue Share by Type in 2019
Figure 64. Global Diabetes Drug Market Share Forecast by Type (2021-2025)
Figure 65. Global Insulin Revenue Growth Rate (2015-2020)
Figure 66. Global Sensitizers Revenue Growth Rate (2015-2020)
Figure 67. Global SGLT-2 Inhibitors Revenue Growth Rate (2015-2020)
Figure 68. Global Alpha-glucosidase Inhibitors Revenue Growth Rate (2015-2020)
Figure 69. Global Secretagogues Revenue Growth Rate (2015-2020)
Figure 70. Global Peptide Analogs Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Diabetes Drug Revenue Share by Application (2015-2020)
Figure 73. Global Diabetes Drug Revenue Share by Application in 2019
Figure 74. Global Diabetes Drug Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospital Revenue Growth Rate (2015-2020)
Figure 76. Global Clinic Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Diabetes Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Diabetes Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Diabetes Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Diabetes Drug Revenue Market Forecast (2021-2025)
Figure 82. Europe Diabetes Drug Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Diabetes Drug Revenue Market Forecast (2021-2025)
Figure 84. South America Diabetes Drug Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Diabetes Drug Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
インスリンドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Insulin Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insulin Drug De…- 糖尿病ケア機器の世界市場 2020年 Market Overview The Diabetes Care Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 糖尿病ケア機器・薬物の世界市場 2020年 Market Overview The global Diabetes Care Devices & Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Care D…
- 糖尿病治療用ペンニードルの世界市場 2020年 Market Overview The global Pen Needles for Diabetes Care market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pen Needles for…
- 糖尿病検査室イムノアッセイの世界市場 2020年 Market Overview The global Diabetes Laboratory Immunoassays market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Lab…